T 0777/17 (Degarelix in metastatic stage prostate cancer/FERRING) of 22.09.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T077717.20200922
- Date of decision
- 22 September 2020
- Case number
- T 0777/17
- Petition for review of
- -
- Application number
- 09711390.6
- IPC class
- A61P 35/04A61K 38/09A61P 35/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of metastatic stage prostate cancer with degarelix
- Applicant name
- Ferring B.V.
- Opponent name
- Generics (UK) Ltd (trading as Mylan)
- Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 13Rules of procedure of the Boards of Appeal Art 13Rules of procedure of the Boards of Appeal Art 25
- Keywords
- Main request, auxiliary requests 2 and 3 - Inventive step (no)
Auxiliary requests 1 and 4 to 7 - admitted into the proceedings (no)
Late-filed argument - admitted into the proceedings (no) - Catchword
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.